Shoulder Innovations, Inc.

NYSE: SI · Healthcare · Medical - Specialties

PublicHQ Grand Rapids, CACIK 0001699350Reports USD

#438 of 1,394 Healthcare companies by revenuetop-quartile growth

EA Score

42D

FH 66DQ 6GM —SS 45

v0.1 · 55/100 weight · provisional

↑ Altman-Z, balance-sheet leverage · ↓ disclosure history, listing tenure

Methodology →

Revenue TTM

$53.9M

Rev growth YoY (TTM)

+55.9%

Net income (FY)

-$40.4M

Employees

Market cap

$441.1M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$47.3M$47.3M2025

Net income-$40.4M-$40.4M2025

Operating income-$26.3M-$26.3M2025

Total assets$169.9M$169.9M2025

Liabilities$29.2M$29.2M2025

Equity$140.8M$140.8M2025

Revenue by segment

Filed disclosures · FY2025

By product

Reportable100%

By geography

Not disclosed.

The read

Shoulder Innovations, Inc. booked $47.3M in FY2025 revenue, growing 50% year over year — faster than most Healthcare companies we track, at a -85.3% net margin.

Peers · Healthcare

Assembly Biosciences, Inc.64C Varex Imaging Corporation66B Vireo Growth Inc.58C Mobia Medical, Inc. Common Stock——

Key facts

CEORobert Joseph Ball

SectorHealthcare

IndustryMedical - Specialties

HeadquartersGrand Rapids, CA

ExchangeNYSE: SI

Employees75

IPO date2025-07-31

Latest filings

8-K2026-06-29 8-K2026-06-26 10-Q2026-05-13 8-K2026-05-13 DEF 14A2026-04-29 8-K2026-04-27 8-K2026-04-14 10-K2026-03-10

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.